The Potential of CAR T-Cell Therapy in Adult ALL

Video

Eunice Wang, MD, and Bijal Shah, MD, MS, discussed unmet needs for adult patients with relapsed/refractory ALL and reflect on the current treatment landscape.

This content originally appeared on our sister site, OncLive.

Related Videos
Amit Soni, MD, the Center for Inherited Blood Disorders
Omid Hamid, MD
Paula Cannon, PhD, the president elect of ASGCT and a distinguished professor of microbiology at Keck School of Medicine of USC
George Tachas, PhD
Alexandra Gomez-Arteaga, MD
Pietro Genovese, PhD, the principal investigator at the Gene Therapy Program of Dana-Farber/Boston Children’s Cancer and Blood Disorder Center
Akshay Sharma, MBBS, a bone marrow transplant physician at St. Jude Children’s Research Hospital
M. Peter Marinkovich, MD, on Bringing RDEB Treatment to the Local Level
Caspian Oliai, MD, MS, the medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Related Content
Around the Helix: Cell and Gene Therapy Company Updates – April 24, 2024

Around the Helix: Cell and Gene Therapy Company Updates – April 24, 2024

April 24th 2024
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center

First Patient With Gastric Cancer Dosed in iNKT/CTLA-4 Inhibitor/Anti-PD-L1 Trial

April 24th 2024
Article

A case study previously described successful immune modulation with AgenT-797 in a patient with high-risk gastric cancer leading to a partial response.

European Commission Approves Janssen and Legend Biotech’s Carvykti for Expanded Indication in Earlier Line Multiple Myeloma

European Commission Approves Janssen and Legend Biotech’s Carvykti for Expanded Indication in Earlier Line Multiple Myeloma

April 23rd 2024
Article

The EC’s decision comes several weeks after the FDA approved cilta-cel for a similar expanded indication.

EGFR-Targeting γδ2T-Cell Cleared for Solid Tumor Trial

EGFR-Targeting γδ2T-Cell Cleared for Solid Tumor Trial

April 22nd 2024
Article

Acepodia is also evaluating a CD20-targeted γδ2T-cell therapy in patients with non-Hodgkin lymphoma.

Alexis Kuhn, PharmD, BCOP, a pediatric oncology pharmacist at Mayo Clinic

Considerations for Administering Hemoglobinopathy Gene Therapies From a Pharmacist’s Perspective

April 20th 2024
Article

Alexis Kuhn, PharmD, BCOP, a pediatric oncology pharmacist at Mayo Clinic, discussed the incorporation of the recently FDA-approved gene therapies for SCD and TDT into the work of pharmacists.

CGTLive®’s Weekly Rewind – April 19, 2024

CGTLive®’s Weekly Rewind – April 19, 2024

April 19th 2024
Article

Review top news and interview highlights from the week ending April 19, 2024.

© 2024 MJH Life Sciences

All rights reserved.